Clinical trial

Dose-Ranging Study Evaluating AVE2268 in Patients With Type 2 Diabetes Not Adequately Controlled by a Metformin Treatment

NCT00361738

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2006-07-01

PhasePHASE2

Study timeline

Study start (unknown)2006-07-01Date precision: month

Registry last updated2009-02-09

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Type 2 Diabetes Mellitusunresolved

Interventions

AVE2268DRUG

Sponsors & collaborators

Sanofilead sponsor

Mapped research locations

ParisFrance1 BerlinGermany1 MilanItaly1 WarsawPoland1 SantiagoChile1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00361738 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.